Who owns Evommune, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of EVMN from SEC Form 13F filings across 105 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 105 institutions disclosed 34.6M shares of Evommune, Inc. worth $462.5M — about 95.7% of shares outstanding; the largest disclosed holder is EQT Fund Management S.a r.l.. Source: SEC Form 13F filings, parsed by EvidInvest.
105
13F holders
$462.5M
value, 2026 filers
95.7%
of shares outstanding (34.6M sh)
41
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of EVMN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EQT Fund Management S.a r.l. | 5.3M | $70.3M | 8.1% | 14.6% | +7.3% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 3.5M | $46.4M | 0.4% | 9.7% | 0.0% |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.9M | $25.8M | 0.0% | 5.4% | +73.4% |
| 4 | Pivotal bioVenture Partners Investment Advisor LLC | 1.9M | $25.6M | 8.3% | 5.3% | 0.0% |
| 5 | JPMORGAN CHASE & CO | 1.6M | $23.4M | 0.0% | 4.3% | +6.4% |
| 6 | RTW INVESTMENTS, LP | 1.5M | $20.0M | 0.2% | 4.2% | 0.0% |
| 7 | Nan Fung Group Holdings Ltd | 1.4M | $19.2M | 14.6% | 4% | 0.0% |
| 8 | Point72 Asset Management, L.P. | 1.4M | $19.1M | 0.0% | 4% | +3823.4% |
| 9 | ANDERA PARTNERS | 1.4M | $18.5M | 9.0% | 3.9% | -26.6% |
| 10 | EVENTIDE ASSET MANAGEMENT, LLC | 1.2M | $16.1M | 0.2% | 3.3% | 0.0% |
| 11 | Vestal Point Capital, LPNEW | 1.0M | $13.3M | 0.3% | 2.8% | new |
| 12 | Jupiter Topco LLCNEW | 896,700 | $11.9M | 0.0% | 2.5% | new |
| 13 | BlackRock, Inc. | 886,538 | $11.8M | 0.0% | 2.5% | +31.6% |
| 14 | VANGUARD CAPITAL MANAGEMENT LLC | 881,895 | $11.7M | 0.0% | 2.4% | +93.8% |
| 15 | BAKER BROS. ADVISORS LP | 847,390 | $11.3M | 0.1% | 2.3% | 0.0% |
| 16 | Defilade Capital Management, L.P. | 793,145 | $10.5M | 1.4% | 2.2% | +16.9% |
| 17 | AMERICAN CENTURY COMPANIES INC | 755,018 | $10.0M | 0.0% | 2.1% | +53.2% |
| 18 | Alyeska Investment Group, L.P. | 704,425 | $9.4M | 0.0% | 1.9% | -3.0% |
| 19 | Balyasny Asset Management L.P.NEW | 457,015 | $6.1M | 0.0% | 1.3% | new |
| 20 | Velan Capital Investment Management LP | 451,255 | $6.0M | 3.7% | 1.2% | +1.1% |
| 21 | UBS Group AG | 413,553 | $5.5M | 0.0% | 1.1% | +38.6% |
| 22 | FEDERATED HERMES, INC. | 325,000 | $4.3M | 0.0% | 0.9% | 0.0% |
| 23 | GREAT POINT PARTNERS LLC | 325,000 | $4.3M | 0.8% | 0.9% | 0.0% |
| 24 | Freestone Grove Partners LP | 306,328 | $4.1M | 0.0% | 0.8% | -9.2% |
| 25 | GEODE CAPITAL MANAGEMENT, LLC | 301,759 | $4.0M | 0.0% | 0.8% | +21.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.